Dopaxol PR Prolonged-release Tablet
Pramipexole (as diHCl monohydrate)
0.75 mg
TABUK PHARMACEUTICAL MANUFACTURING CO
| Pack size | 30's Pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 5.39 AED |
Available as:
Indications
Dopaxol PR Prolonged-release Tablet is used for:
For the treatment of signs and symptoms of idiopathic Parkinson's disease
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Pramipexole (as diHCl monohydrate) :
Mechanism of Action
The precise mechanism of action of Pramipexole as a treatment for Parkinson's disease is unknown, although it is believed to be related to its ability to stimulate dopamine receptors in the striatum.
Note
Dopaxol PR 0.75 mg Prolonged-release Tablet manufactured by TABUK PHARMACEUTICAL MANUFACTURING CO. Its generic name is Pramipexole (as diHCl monohydrate). Dopaxol PR is availble in Saudi Arabia.
Farmaco SA drug index information on Dopaxol PR Prolonged-release Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.